A ground-breaking innovation
in diabetes management

Insulin pump therapy can help people with diabetes more accurately deliver their insulin doses than with manual injections, provide more consistent blood sugar levels, and improve their A1C — all without the need for multiple daily injections.1 But even with the best equipment, insulin flow interruptions can still happen.

That's why BD is excited about a collaboration with the JDRF (a leading global organization focused on type 1 diabetes research) and the Helmsley Charitable Trust to develop a ground-breaking new innovation in insulin infusion sets featuring BD FlowSmart™ Technology.

The patent-pending BD FlowSmart™ Technology uses a unique side opening to help insulin flow, even if the cannula tip is blocked2. If the tip is blocked and the insulin gets backed up, it can flow through the side-port, ensuring the delivery continues.

Click here to see data



MiniMed® Pro-set® with
BD FlowSmart™ Technology

BD and Medtronic are working together to make this exciting new insulin infusion set available.

Learn more and sign up for updates

1. American Diabetes Association. Advantages of using an insulin pump. Available at http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication/insulin/advantages-of-using-an-insulin-pump.html. December 9, 2013.
2. Bolick, Natasha, et al. "Reduction of Flow Interruptions Occurrence During Continuous Subcutaneous Insulin Infusion." ATTD. Paris, France, 2015.

Important Note: The content of this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Do not disregard your doctor's advice or delay in seeking it because of something you have read in this website.
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company.
© 2016 BD Inc. Patent pending.

MiniMed and Pro-set are registered trademarks of Medtronic MiniMed Inc.